Table 4 Longitudinal analysis of change in medication as secondary outcome
Univariate model | Multivariable model | |||
|---|---|---|---|---|
Odds ratio (95% CI) | P value | Odds ratio (95% CI) | P value | |
Nocturnal symptoms | 2.63 (1.74–3.97) | <0.001 | 2.87 (1.88–4.38) | <0.001 |
Age (per year) | 1.01 (1.00–1.17) | 0.038 | 1.01 (1.00–1.02) | 0.007 |
Period of medication usage (per month) | 1.01 (1.00–1.02) | 0.217 | ||
Gender (Male versus Female) | 0.97 (0.65–1.44) | 0.86 | — | — |
Race | ||||
Malay versus Chinese | 0.78 (0.47–1.30) | 0.34 | — | — |
Indian versus Chinese | 0.86 (0.47–1.58) | 0.63 | — | — |
Others versus Chinese | 1.21 (0.46–3.19) | 0.38 | — | — |
Allergic rhinitis (Yes versus No) | 0.95 (0.61–1.48) | 0.38 | — | — |
Allergic conjunctivitis (Yes versus No) | 1.51 (0.14–16.7) | 0.73 | — | — |
Eczema (Yes versus No) | 0.74 (0.29–1.91) | 0.53 | — | — |
Current visit (relative to last visit) | 1.03 (0.99–1.07) | 0.12 | — | — |
